Target intelligence / Profile preview

MicroRNA 3156-1 (MIR3156-1)

Target
MIR3156-1
Molecular classification
MicroRNA, small non-coding RNA, non-coding regulatory RNA
01

Overview

MicroRNA 3156-1 (MIR3156-1) is a human microRNA gene encoding a small non-coding RNA molecule processed into mature forms such as miR-3156-5p, which regulate the expression of target mRNAs by promoting their degradation or inhibiting their translation. MIR3156-1 does not encode a protein and is considered part of the broad class of post-transcriptional regulatory molecules involved in fine-tuning gene expression. Recent studies indicate that miR-3156-5p, processed from the MIR3156-1 locus, is involved in the pathophysiology of various cancers (breast, lung, colorectal, thyroid, and neuroendocrine) and may regulate tumor proteins such as MORF4L2. Its differential serum levels in cancer patients suggest utility as a prognostic and therapeutic response biomarker; however, its exact gene targets and molecular actions remain incompletely characterized[4][5].

Other names
hsa-mir-3156-1mir-3156-1MIR3156-1
02

Mechanism of action

Not applicable for direct drug targeting, but miR-3156-1 (specifically miR-3156-5p, its mature processed product) regulates the expression of various genes (such as MORF4L2, CASP2, and TPT1-AS1), thus indirectly impacting cancer therapy response[4].

03

Biological functions

Regulation of mRNA translation and stabilityPost-transcriptional gene silencingModulation of cell-cycle progressionPossible influence on apoptosis and cell proliferation through target regulation
04

Disease associations

Cancer (roles in multiple tumor types such as breast, colorectal, lung, and thyroid cancer; shown to affect progression, prognosis, and sensitivity to treatment)Neuroendocrine tumors (MEN1 syndrome; downregulated in serum of MEN1 patients)
05

Safety considerations

None documented specific to MIR3156-1as with all microRNAs used as biomarkers or therapeutic agents, issues relate to specificity, off-target effects, and delivery challenges
06

Biomarkers

miR-3156-5p may serve as a serum biomarker for cancer detection, progression monitoring, and evaluating therapeutic response, specifically in colorectal and neuroendocrine tumors

Beyond the preview

Go deeper on MicroRNA 3156-1 (MIR3156-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA 3156-1 (MIR3156-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call